| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Jan 30, 2024 | Option Exercise | $9.80 | 2,175 | 21,315 | 40,391 | Feb 01, 2024, 06:00 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Jan 31, 2024 | Option Exercise | $2.69 | 4,621 | 12,430 | 45,012 | Feb 01, 2024, 06:00 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Dec 29, 2023 | Option Exercise | $11.25 | 3,044 | 34,245 | 33,291 | Jan 02, 2024, 06:00 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Jul 31, 2023 | Option Exercise | $2.81 | 1,825 | 5,128 | 23,835 | Aug 02, 2023, 05:51 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Mar 24, 2023 | Buy | $4.31 | 10,000 | 43,140 | 22,010 | Mar 24, 2023, 08:54 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Jan 31, 2023 | Option Exercise | $10.21 | 1,172 | 11,964 | 12,010 | Feb 02, 2023, 05:09 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Dec 31, 2022 | Option Exercise | $16.45 | 3,028 | 49,811 | 10,838 | Jan 03, 2023, 05:59 PM | |
| ALT | Altimmune, Inc. | Eisenstadt Richard I | Chief Financial Officer | Jul 31, 2022 | Option Exercise | $6.86 | 1,366 | 9,371 | 1,366 | Aug 03, 2022, 04:05 PM | |
| NEOS | Neos Therapeutics, Inc. | Eisenstadt Richard I | Chief Financial Officer | Mar 01, 2021 | Option Exercise | $0.88 | 1,390 | 1,227 | 141,070 | Mar 16, 2021, 08:49 AM | |
| NEOS | Neos Therapeutics, Inc. | Eisenstadt Richard I | Chief Financial Officer | Mar 02, 2021 | Option Exercise | $0.84 | 14,825 | 12,512 | 126,245 | Mar 16, 2021, 08:49 AM | |
| NEOS | Neos Therapeutics, Inc. | Eisenstadt Richard I | Chief Financial Officer | Dec 12, 2018 | Buy | $2.16 | 5,000 | 10,819 | 42,460 | Dec 13, 2018, 04:08 PM | |
| NEOS | Neos Therapeutics, Inc. | Eisenstadt Richard I | Chief Financial Officer | Aug 25, 2016 | Buy | $6.82 | 3,710 | 25,284 | 3,710 | Aug 25, 2016, 04:34 PM |
Menu